HK1030551A1 - Antimicrobial peptides - Google Patents

Antimicrobial peptides

Info

Publication number
HK1030551A1
HK1030551A1 HK01101609A HK01101609A HK1030551A1 HK 1030551 A1 HK1030551 A1 HK 1030551A1 HK 01101609 A HK01101609 A HK 01101609A HK 01101609 A HK01101609 A HK 01101609A HK 1030551 A1 HK1030551 A1 HK 1030551A1
Authority
HK
Hong Kong
Prior art keywords
seq
peptides
antimicrobial peptides
dmpiqafllyqqpvlgpvr
avestvatledspeviesppe
Prior art date
Application number
HK01101609A
Other languages
English (en)
Inventor
Eric Charles Reynolds
Stuart Geoffrey Dashper
Neil Martin O'brien-Simpson
Gert Hoy Talbo
Marina Malkoski
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of HK1030551A1 publication Critical patent/HK1030551A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK01101609A 1997-11-24 2001-03-06 Antimicrobial peptides HK1030551A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP0514A AUPP051497A0 (en) 1997-11-24 1997-11-24 Antimicrobial peptides
PCT/AU1998/000972 WO1999026971A1 (en) 1997-11-24 1998-11-24 Antimicrobial peptides

Publications (1)

Publication Number Publication Date
HK1030551A1 true HK1030551A1 (en) 2001-05-11

Family

ID=3804794

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101609A HK1030551A1 (en) 1997-11-24 2001-03-06 Antimicrobial peptides

Country Status (10)

Country Link
US (1) US7588752B2 (de)
EP (1) EP1032592B1 (de)
JP (1) JP4940439B2 (de)
AT (1) ATE368053T1 (de)
AU (1) AUPP051497A0 (de)
CA (1) CA2311389C (de)
DE (1) DE69838143T2 (de)
HK (1) HK1030551A1 (de)
WO (1) WO1999026971A1 (de)
ZA (1) ZA9810679B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
GB0001825D0 (en) * 2000-01-26 2000-03-22 Regen Therapeutics Plc Peptides
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
NZ531639A (en) 2001-08-23 2006-02-24 Westgate Biolog Ltd Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
KR100944204B1 (ko) 2001-09-15 2010-02-26 러쉬 유니버시티 메디컬 센터 중층 연골 조직 및 그것을 조작하는 방법
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
US7790670B2 (en) 2002-03-01 2010-09-07 Glanbia Nutritionals (Ireland) Ltd. Compositions and methods for treatment of body weight conditions
KR100441402B1 (ko) * 2002-03-26 2004-07-23 한국과학기술원 항균 활성을 갖는 펩타이드, 이들의 유도체 및 이들을포함하는 항균 조성물
WO2003091429A1 (fr) 2002-04-25 2003-11-06 Toagosei Co.,Ltd. Polypeptide microbicide et ses utilisations
US8778889B2 (en) 2003-03-10 2014-07-15 The United States Of America As Represented By The Secretary Of The Army Antimicrobial decapeptide oral hygiene treatment
DE10331202A1 (de) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
EP1688486B1 (de) 2003-10-29 2016-12-14 Toagosei Co., Ltd. Antibakterielles peptid und seine nutzung
AU2004298285B2 (en) * 2003-12-19 2010-06-24 Dairy Australia Limited Antimicrobial composition
JP4507080B2 (ja) 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
JP4656288B2 (ja) * 2004-08-19 2011-03-23 ライオン商事株式会社 動物用オーラルケア用ペットフードの製造方法
JP4730584B2 (ja) 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
US20090030179A1 (en) 2005-02-15 2009-01-29 Toagosei Co., Ltd Antimicrobial peptide and use thereof
US7754687B2 (en) * 2005-02-24 2010-07-13 Mount Sinai School Of Medicine Methods of inhibiting viral infection
ES2319475B1 (es) 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
JP2009516645A (ja) * 2005-10-18 2009-04-23 ザ ユー．エス． ガバメント アズ リプレゼンテッド バイ ザ セクレタリー オブ ジ アーミー 抗菌デカペプチド口腔衛生処置
DE102006036285A1 (de) * 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
US20080264479A1 (en) 2007-04-25 2008-10-30 Nanoco Technologies Limited Hybrid Photovoltaic Cells and Related Methods
WO2009033824A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a combination of beta-casokinin and cnp-22 as a therapeutic agent
AU2010203698B2 (en) * 2009-01-06 2016-07-21 C3 Jian, Inc. Targeted antimicrobial moieties
AU2010262763A1 (en) * 2009-06-19 2012-01-19 Oral Health Australia Pty Ltd Casein derived protease inhibitory peptides
AU2010317661A1 (en) * 2009-11-11 2012-05-31 Oral Health Australia Pty Ltd Antibiofilm glycopeptides
EP2825606A4 (de) * 2012-03-13 2015-12-02 Sigge & Martin Ab Prof Natürliches schützendes gelsystem
ITMI20122263A1 (it) 2012-12-28 2014-06-29 Azienda Ospedaliero Universitaria Di Parma Nuovi peptidi cationici ciclici ad attività antimicrobica
CN113045628B (zh) * 2021-03-23 2022-06-14 山东大学 一种抗菌肽或其变体在制备抗菌产品中的应用
CN113717267B (zh) * 2021-09-02 2023-02-28 湖南师范大学 一种抗菌肽pHTP-1及其应用和包含抗菌肽pHTP-1的产品
CN113717254B (zh) * 2021-09-23 2022-03-22 中山大学附属口腔医院 一种抗菌肽及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1315480C (en) * 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
CH671879A5 (de) * 1987-02-26 1989-10-13 Nestle Sa
ES2084150T3 (es) * 1989-12-22 1996-05-01 Commw Scient Ind Res Org Aminoacidos, peptidos o sus derivados asociados a las grasas.
US5583198A (en) * 1989-12-22 1996-12-10 Commonwealth Scientific And Industrial Research Organization Amino acids, peptides or derivatives thereof coupled to fats
FR2686085B1 (fr) * 1992-01-10 1995-08-04 Agronomique Inst Nat Rech Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations.
JPH07278013A (ja) * 1994-03-31 1995-10-24 Snow Brand Milk Prod Co Ltd エンドトキシン中和剤
GB9409387D0 (en) 1994-05-11 1994-06-29 Unilever Plc Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque
ZA962939B (en) * 1995-04-12 1997-10-13 Quest Int Oral care compositions.

Also Published As

Publication number Publication date
US7588752B2 (en) 2009-09-15
WO1999026971A1 (en) 1999-06-03
CA2311389A1 (en) 1999-06-03
EP1032592A1 (de) 2000-09-06
EP1032592A4 (de) 2004-10-20
ZA9810679B (en) 1999-07-30
DE69838143T2 (de) 2008-04-10
CA2311389C (en) 2011-02-15
JP4940439B2 (ja) 2012-05-30
US20030195150A1 (en) 2003-10-16
AUPP051497A0 (en) 1997-12-18
DE69838143D1 (de) 2007-09-06
EP1032592B1 (de) 2007-07-25
ATE368053T1 (de) 2007-08-15
JP2002503641A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
ZA9810679B (en) Antimicrobial peptides.
EP1803733A3 (de) Behandlung von Entzündungen
NZ503850A (en) April - a novel protein with growth effects
IL113617A0 (en) Soluble polypeptide fraction
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
EP1939293A3 (de) Interferonähnliches Protein ZCYTO21
WO2002072616A3 (en) Transfection complexes
GB9606040D0 (en) Active peptide
EP0733071A4 (de) Chaperonin - antagonisten
EP1006126A3 (de) Peptide mit osteogener Aktivität
CA2020663A1 (en) Substitution analogues of magainin peptides
AU3850997A (en) Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
AU5776799A (en) Modified hcv peptide vaccines
EP0384731A3 (de) Osteogenische Wachstumfaktoren, die aus sich regenerierendem Knochenmark identifiziert werden
PT773999E (pt) Receptor orfao or-1 pertencente a familia de receptores nucleares
EP0919621A4 (de) Menschliche tak1 und für diese kodierende dna
EP0858808A3 (de) Peptide zur Verwendung in Wundbehandlung
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
EP0723016A3 (de) Leukocyten-aktivierender Faktor
CA2244928A1 (en) Dna coding for serine/threonine kinase
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ES2178911A1 (es) Peptidos bioactivos derivados de las transferrinas.
EP1158052A4 (de) Beta-primeverosidase gen
GB0008504D0 (en) Novel polypeptide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141124